跳至主要内容
临床试验/CTRI/2023/02/049693
CTRI/2023/02/049693尚未招募3 期

A CLINICAL EVALUATION OF SIDDHA HERBAL FORMULATION PANCHATHAARAI KUZHAMBU(INTERNAL MEDICINE) AND OTTRAI THALAIVALI THYLAM(EXTERNAL MEDICINE)IN THE MANAGEMENT OF OTTRAI THALAIVALI(MIGRAINE)AMONG OUT-PATIENTS ATTENDING AYOTHIDOSS PANDITHAR HOSPITAL, NATIONAL INSTITUTE OF SIDDHA

ational Institute of Siddha0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Five migraine attacks, in the last 3 months each lasting for 4-72 hours and having any
  • two of the following characteristics,
  • a) Headache of unilateral location,
  • b) Pulsating quality,
  • c) Mild to moderate intensity
  • d) Aggravation by routine physical activity.
  • Patient must have at least any one of the following symptoms,
  • a) Often accompanied by nausea (and/or vomiting).
  • b) Sensitivity to light and sound.
  • â?ª Headache Impact Test total score range 36-59 will be included
  • â?ª Patient who is willing to participate in the study by signing consent and fulfilling the
  • conditions of Proforma.

排除标准

  • Cervical spondylosis
  • Cerebro vascular diseases
  • Trigeminal neuralgia.
  • Traumatic history
  • Psychiatric illness
  • Sinusitis headaches
  • Ear disorders
  • Eye diseases
  • Diabetes mellitus
  • Hypertension
  • Patient with any other serious systemic diseases.

研究者

相似试验